Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1307197 Title: COMPOSITIONS POUR LE TRAITEMENT DU CANCER CONTENANT UN INHIBITEUR DE TOPOISOMERASE ET THALIDOMIDE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
019353739
WO application number:
US2001015327
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
1307197
WO publication number:
WO 2001/087307
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
10/05/2001
Grant date:
05/04/2006
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
28/04/2006
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
05/04/2006
EP B1 publication date:
05/04/2006
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/05/2015
Expiration date (if granted and all annual fees paid):
10/05/2021

Applicant

Name:
CELGENE CORPORATION
Legal Form:
From:
05/04/2006
Address:
86 Morris Avenue, Summit, New Jersey 07901, -, United States (US)
To:

Agent

Name:
COLENS Alain
Legal Form:
From:
28/04/2006
Address:
Square Marie Louise 40 Bte 19, 1000, BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
ZELDIS, Jerome, B.
Legal Form:
Address:

2

Name:
BARER, Sol
Legal Form:
Address:

3

Name:
ZEITLIN, Andrew
Legal Form:
Address:

Priority

Priority patent number:
204143
Priority date:
15/05/2000
Priority country:
United States (US)

Classification

Main IPC class:
A61K 31/47;
IPC or IDT classification:
A61P 35/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2006/04
Publication date:
30/04/2006
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2015/11
Publication date:
16/09/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
30/05/2014
Last annual fee paid number:
14
Last annual fee paid amount:
290 Euro
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
28/04/2006 General Document (TP - T:Traduction Originale plus Pouvoir) 89 PDF /7/9/1/7/0/0611307197/migrated-docs/019353739_1_200292.pdf
16/11/2006 General Document (CAD - S:Changement d'adresse) 3 PDF /7/9/1/7/0/0611307197/migrated-docs/019353739_2_200292.pdf